A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
Clinical trial NCT06461897 · RECRUITING
Trial details
- NCT number
- NCT06461897
- Sponsor
- AbbVie
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-19
- Primary completion
- 2030-07-01
- Enrollment
- 675
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.